Pharmaceutical Executive, Apr 1, 2008 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Apr 1, 2008
Features
Money-Back Guarantee
By Thomas Nagle
...and other ways you never thought to sell your drugs
On-The-Job Off-Label Compliance
By Fred Eaton , Mark Scallon
Pharm Exec presents a user's guide to minimizing your company's risk areas (all 80 of them).
The Navigator: Charlotte Sibley
By Joanna Breitstein
Here's the saga of how market research, health outcomes, and dozens of other tools that connect the industry to patients came to be.
Chinese Puzzle
By Walter Armstrong
The contamination of heparin in China cast the drugmaker, its US supplier, and FDA as indifferent and incompetent. Then the story took a very strange turn...
Washington Report
Supply Chains Without Borders
By Jill Wechsler
International outsourcing carries risks for marketers and regulatory challenges for FDA
From the Editor
Molecular Fraud
By Patrick Clinton
The real question in the Baxter heparin scandal is not who's guilty but whether pharma can get reliable results from a country in chaos
Molecular Fraud
By Patrick Clinton
The real question in the Baxter heparin scandal is not who's guilty but whether pharma can get reliable results from a country in chaos
Global Report
British Biotech Blues
By Sarah Houlton
Can ceasing trade sales and finding funding help UK biotechs became an industry in their own right?
Commentary
Putting the "I" in "Team"
By Margaret-Ann Cole
Pharma is embracing the cross-functional team. But that doesn't mean that you must blend in with the sheep. Putting your best foot forward strengthens the team...and you.
Leadership
The WIIFM Initiative
By Sander A. Flaum
Everyone likes to work for a successful company. But how do you drive your initiatives to the top? Never underestimate courage and persistence.
Legal
Mind the (Tax) Gap
By Erika A. Kelton
A little-known provision in a new law rewards employees for blowing the whistle on tax fraud. Pharma should examine its tricky tax situation—and work out the issues on a global level.
Column
How to Wow the Docs
By Michael Shaw , Charles Goetz
Talk to MDs in their language and build a better brand
Let's Play Pharmazooticals
By Walter Armstrong
When it comes to developing novel therapies from the animal kingdom, it's mostly a game of pick your poison
Tracking Pharma Consumers Online
New study ranks the top RX product sites and looks at the consumers who view them
The Hispanic Factor
By Jane Finney
What Big Pharma needs to learn—and value—about this rapidly growing US demographic
Thought Leader
Valuing Diversity
By Reggie Smith
Veteran salesperson Reggie Smith of Genentech makes the case for sales force diversity

ADVERTISEMENT

Click here